-+ 0.00%
-+ 0.00%
-+ 0.00%

Tharimmune Expanded Its Product Pipeline With HS1940, A Dual-target Multispecific Biologic Engineered To Bind To Both Programmed Death-1 And Vascular Endothelial Growth Factor Receptors

Benzinga·03/04/2025 12:07:23
Listen to the news

Using its proprietary EpiClick Technology, a versatile multispecific antibody engineering platform, HS1940 represents a key expansion of Tharimmune's product pipeline